Langasog, Amara Kaye Q.
HRN: 21-89-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
CEFUROXIME 750MG (VIAL)
09/14/2022
09/20/2022
IV
630mg
Q8
Age With Moderate Dehydration, T/c UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes